Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Fosaprepitant

An intravenous prodrug of aprepitant: it blocks the NK1 receptors for substance P and was approved in the United States in 2008 to prevent chemotherapy-induced nausea and vomiting. This family brings together the active ingredient, labelled standards and other impurities.

Did you know?Substance P, the neuropeptide whose action it blocks, was discovered in 1931 by Ulf von Euler and John Gaddum: the P is said to stand for 'preparation' or 'powder', the form of the original extract.

FosaprepitantGo to the active ingredient →
FosaprepitantActive ingredientFosaprepitantCat. No. P-F117-001CAS 172673-20-0

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.